Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy.

E Beutler1

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA. beutler@scripps.edu

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|October 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1342C mutation in Gaucher's disease.

Lancet (London, England)·1995
Same author

Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.

American journal of hematology·1995
Same author

Gaucher disease.

Medicine·1995
Same author

Treatment regimens in Gaucher's disease.

Lancet (London, England)·1995
Same author

Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

The Journal of clinical investigation·1995
Same author

Erythrocyte fragility and chronic intermittent pigmenturia in a dog.

Journal of the American Veterinary Medical Association·1995
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

End of headings.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

ASTCT Notes.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2021
Same journal

Improving Hematopoietic Stem Cell Transplant in the Elderly: Can We Finally Start to Impact Nonrelapse Mortality?

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
Same journal

Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2020
See all related articles

Gene therapy aims to treat diseases by correcting faulty genes. Recent advances in viral and nonviral vectors show promise for effective human gene therapies in the near future.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Genetics

Background:

  • Gene therapy research has focused on treating genetic and acquired diseases for two decades.
  • Current treatments are limited for many diseases, driving the need for novel therapeutic approaches.

Purpose of the Study:

  • To review the progress and challenges in developing gene therapy for human diseases.
  • To highlight advancements in gene transfer vectors and mutation correction techniques.

Main Methods:

  • Utilizing viral vectors, which efficiently deliver DNA into host cells.
  • Employing nonviral vectors, which are improving in efficiency for gene delivery.
  • Focusing on hematopoietic stem cells for in vitro gene transduction due to ease of manipulation.

Related Experiment Videos

Main Results:

  • Significant improvements in vector efficiency and gene-editing techniques over the past 20 years.
  • Hematopoietic stem cells are a viable target for gene therapy, particularly for diseases responsive to transplantation.

Conclusions:

  • While effective human gene therapy remains a challenge, recent scientific progress offers optimism for its realization.
  • Continued advancements in vector technology and gene correction strategies are crucial for future therapeutic success.